The Scientist

» congress and disease/medicine

Most Recent

image: Mapping Zoonotic Disease

Mapping Zoonotic Disease

By | June 14, 2016

Researchers aim to predict new infectious disease outbreaks that spread from animals to humans.

0 Comments

image: Altered Sense of Touch in Autism?

Altered Sense of Touch in Autism?

By | June 10, 2016

A mouse study suggests that disruptions to nerves in the skin may contribute to autism spectrum disorder.

1 Comment

image: Update to US Chemical Regulations Expected

Update to US Chemical Regulations Expected

By | June 8, 2016

Following approval by Congress, the president will decide on an update the 1976 Toxic Substances Control Act.

0 Comments

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Contributors

Contributors

By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

1 Comment

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

image: House Passes Watered-Down Zika Aid Bill

House Passes Watered-Down Zika Aid Bill

By | May 20, 2016

The legislation allocates only $622 million to the effort to help the country respond to the impending spread of the mosquito-borne disease.

1 Comment

The US Senate is reviewing a bill that would extend a ban on so-called three-parent embryos.

0 Comments

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS